NYSEAMERICAN:NSPR

InspireMD Stock Forecast, Price & News

$4.33
-0.31 (-6.68 %)
(As of 07/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.26
$4.84
50-Day Range
$4.83
$6.60
52-Week Range
$4.04
$22.20
Volume1.75 million shs
Average Volume912,141 shs
Market Capitalization$34.25 million
P/E RatioN/A
Dividend YieldN/A
Beta1.83
30 days | 90 days | 365 days | Advanced Chart
Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.


InspireMD logo

About InspireMD

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.55 out of 5 stars

Medical Sector

533rd out of 2,214 stocks

Surgical & Medical Instruments Industry

46th out of 181 stocks

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

Is InspireMD a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" InspireMD stock.
View analyst ratings for InspireMD
or view top-rated stocks.

What stocks does MarketBeat like better than InspireMD?

Wall Street analysts have given InspireMD a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but InspireMD wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting InspireMD?

InspireMD saw a decrease in short interest in June. As of June 15th, there was short interest totaling 106,200 shares, a decrease of 30.3% from the May 31st total of 152,300 shares. Based on an average daily volume of 463,000 shares, the days-to-cover ratio is currently 0.2 days. Currently, 1.4% of the company's shares are sold short.
View InspireMD's Short Interest
.

When is InspireMD's next earnings date?

InspireMD is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for InspireMD
.

How were InspireMD's earnings last quarter?

InspireMD, Inc. (NYSEAMERICAN:NSPR) issued its quarterly earnings data on Tuesday, May, 11th. The medical equipment provider reported ($0.53) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.60) by $0.07. The medical equipment provider earned $1.01 million during the quarter. InspireMD had a negative net margin of 480.63% and a negative trailing twelve-month return on equity of 58.60%.
View InspireMD's earnings history
.

When did InspireMD's stock split? How did InspireMD's stock split work?

InspireMD's stock reverse split before market open on Tuesday, April 27th 2021. The 1-15 reverse split was announced on Wednesday, April 14th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 26th 2021. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 7 shares after the split.

What price target have analysts set for NSPR?

1 brokerages have issued 12 month price objectives for InspireMD's stock. Their forecasts range from $10.50 to $10.50. On average, they anticipate InspireMD's stock price to reach $10.50 in the next year. This suggests a possible upside of 142.5% from the stock's current price.
View analysts' price targets for InspireMD
or view top-rated stocks among Wall Street analysts.

Who are InspireMD's key executives?

InspireMD's management team includes the following people:
  • Mr. Marvin L. Slosman, Pres, CEO & Director (Age 56, Pay $526.98k)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 60, Pay $525.32k)
  • Mr. Roei Samuri, VP of Operations
  • Mr. Andrea Tommasoli, Sr. VP of Global Sales & Marketing
  • Mr. Amir Kohen, VP of Fin. & International HR
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 74)

Who are some of InspireMD's key competitors?

What other stocks do shareholders of InspireMD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Palatin Technologies (PTN), Biocept (BIOC), TransEnterix (TRXC), Catalyst Pharmaceuticals (CPRX), Curis (CRIS), iBio (IBIO), Inovio Pharmaceuticals (INO), Verastem (VSTM), AVEO Pharmaceuticals (AVEO) and Inpixon (INPX).

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $4.33.

How much money does InspireMD make?

InspireMD has a market capitalization of $34.25 million and generates $2.48 million in revenue each year.

How many employees does InspireMD have?

InspireMD employs 45 workers across the globe.

What is InspireMD's official website?

The official website for InspireMD is www.inspiremd.com.

Where are InspireMD's headquarters?

InspireMD is headquartered at 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553 or via email at [email protected]


This page was last updated on 7/25/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.